4//SEC Filing
Gryaznov Sergei 4
Accession 0000899243-22-029752
CIK 0001878313other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 4:47 PM ET
Size
6.9 KB
Accession
0000899243-22-029752
Insider Transaction Report
Form 4
Gryaznov Sergei
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2022-08-24$1.80/sh+10,000$18,000→ 34,511 total - Exercise/Conversion
Stock Options
2022-08-24−10,000→ 48,000 totalExercise: $1.80Exp: 2029-11-30→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]Represents the right to buy shares of Common Stock granted pursuant to the 2018 Stock Option Plan. These options vested in four equal monthly installments beginning on December 1, 2019.
Documents
Issuer
MAIA Biotechnology, Inc.
CIK 0001878313
Entity typeother
Related Parties
1- filerCIK 0001913228
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 4:47 PM ET
- Size
- 6.9 KB